US FDA approves Eli Lilly’s advanced breast cancer drug combo
Eli Lilly said the US FDA has approved its drug combination to treat adults with advanced breast cancer that has spread to other parts of the body.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.